Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus [Phase 2]
Phase 2 clinical trial evaluating intravenous ganaxolone as adjunctive therapy for status epilepticus (completed; results posted).
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Possible Immuno-Modulatory Effect of Tocilizumab in Patients With Refractory Status Epilepticus. [Phase 3]
Phase 3 clinical trial investigating tocilizumab for possible immunomodulatory effects in patients with refractory status epilepticus.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Adjunctive Everolimus Treatment of Refractory Epilepsy [Phase 2]
Phase 2 clinical trial update on adjunctive everolimus for refractory epilepsy.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures [Phase 3]
A Phase 3 trial evaluating lacosamide as add-on therapy for children with epilepsy characterized by partial-onset seizures has completed, wi…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME) [NA]
Completed clinical trial TIME studied targeted self-management for epilepsy and serious mental illness; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Behavioral Economics and Adherence in Teens (BEAT!) [NA]
Completed clinical trial BEAT! investigating behavioral economics and adherence in teens for epilepsy, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: CX-8998 for Absence Seizures [Phase 2]
Phase 2 clinical trial of CX-8998 for epilepsy (absence seizures) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 [Phase 2]
A Phase 2 clinical trial update describes a treatment use protocol for subjects continuing from an open-label extension (0601) in epilepsy, …
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Microelectrodes in Epilepsy [NA]
Clinical trial update on microelectrodes for epilepsy has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies [Phase 2]
Phase 2 open-label trial of ganaxolone in children with PCDH19 female pediatric epilepsy and other rare genetic epilepsies completed with re…
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy [Phase 3]
Open-label long-term Phase 3 study of adjunctive brivaracetam in pediatric epilepsy completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Safety of Autologous MSC Infusion to Treat Epilepsy [Phase 1, Phase 2]
Clinical trial update on the safety of autologous mesenchymal stem cell infusion for epilepsy (Phase 1/Phase 2 completed).
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam [Phase 4]
Phase 4 trial updates the effect of pyridoxine on behavioral adverse events associated with levetiracetam in epilepsy.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Lacosamide in Neonatal Status Epilepticus [Phase 3]
Phase 3 clinical trial update for lacosamide in neonatal status epilepticus; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes [Phase 3]
Open-label extension study of cannabidiol (GWP42003-P) in children and adults with Dravet or Lennox-Gastaut syndromes completed; results pos…
-
CLINICAL_TRIALS trial_result · 2022-01-31Clinical Trial Update: Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects [Phase 3]
A Phase 3 repeat-dose safety study in epilepsy subjects has completed, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy [Phase 2]
Phase 2 open-label trial assessing safety, tolerability, and efficacy of oral lacosamide in children with epilepsy completed.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: EMR Outcomes: Anxiety and Depression in Epilepsy [NA]
Clinical trial update reporting outcomes on anxiety and depression related to epilepsy, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy [Phase 4]
A Phase 4 clinical trial evaluating a probiotic in adult patients with drug-resistant epilepsy has been completed.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Fycompa Titration Intervals and Effects on Retention Rate [Phase 4]
Phase 4 trial evaluating Fycompa (perampanel) titration intervals and their impact on retention rate in epilepsy.
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy [Phase 2]
Phase 2 trial evaluating pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients aged 1 month to under …
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Effects of Perampanel on Cognition and Electroencephalography in Patients With Epilepsy [Phase 4]
Phase 4 trial evaluating the effects of perampanel on cognition and EEG in patients with epilepsy has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Correlation of Serum Level of Perampanel (PER) Level to Cerebrospinal Fluid (CSF) Levels of PER [Phase 4]
Phase 4 trial update investigating the correlation between serum perampanel levels and cerebrospinal fluid levels in epilepsy/seizures patie…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Vitamin D Supplementation to Prevent Vitamin D Deficiency for Children With Epilepsy [Phase 3]
Phase 3 trial evaluating vitamin D supplementation to prevent vitamin D deficiency in children with epilepsy has completed.